An Innovative Home Stroke Rehabilitation and Monitoring System

描述（由申请人提供）：该提案展示了一种新型医疗保健提供系统，该系统有可能显著推进卒中康复监测和治疗。广泛的长期目标是为农村和服务不足地区的人们提供可获得的，负担得起的中风护理。一个主要的公共卫生问题是中风幸存者接受的治疗的质量和数量的变化，基于他们接近主要的大都市医疗中心。该提案评估了一个中风患者监测系统和提供最先进的中风治疗，为农村居民提供便利。这一综合康复服务系统利用基于Web的平台存储和检索患者信息，并结合易于使用的可远程监控的机器人治疗设备。收集的数据自动输入系统并发送到数据中心（对用户透明），临床医生通过安全网站监控信息。为了证明该系统的功能，使用现有的用户友好的家庭兼容的中风治疗机器人设备。一项随机、对照、多中心临床试验旨在评估这种结合远程医疗组件的卒中幸存者对照康复治疗。该模型可以在未来推广使用其他基于家庭的治疗和监测设备，根据具体患者的需要。通过使用这些设备促进有效的家庭治疗将有助于确定功能独立和养老院安置之间的差异。该临床试验将招募96名中风患者，并在家中治疗他们三个月。这些重要的考虑因素结合了联合收割机提供服务的现代技术和节省费用的潜力。在相对较短的时间内，这些进展将对向数百万农村中风幸存者提供中风治疗产生重大有益影响。Kinetic Muscles，Inc.是一家新兴公司，开发最先进的治疗设备，从根本上改善中风或创伤性脑损伤（TBI）等神经损伤患者的康复。作为一家早期的医疗器械公司，我们定期寻求私人资金来支持增长目标。这一提议的资金不仅将使KMI能够保留和增加四名全职研发人员，而且还将促进私人投资界的额外资金，以加速创新远程康复治疗的市场部署。这一战略具有现实的能力，为中风患者提供一个新的水平的可获得的，负担得起的康复护理。据估计，目前的提案还将在克利夫兰诊所和埃默里大学之间创造或保留四个工作岗位。 公共卫生相关性：本研究的目的是评估一种治疗系统，为中风患者提供方便，负担得起的中风护理。用户友好的家庭治疗机器人和远程康复系统相结合，以监测和提供治疗，是在农村和服务不足的地区的患者。

DESCRIPTION (provided by applicant): This proposal demonstrates a novel healthcare delivery system that has the potential to significantly advance stroke rehabilitation monitoring and therapy. The broad, long-term objective is to provide accessible, affordable stroke care for people in rural and underserved areas. A major public health issue is the variability in the quality and quantity of treatment that stroke survivors receive based on their proximity to major metropolitan medical centers. This proposal evaluates a system of stroke patient monitoring and delivery of state-of-the-art stroke therapy for that is accessible for rural residents. This comprehensive rehabilitation delivery system utilizes Web-based platforms for storage and retrieval of patient information in conjunction with easy-to-use robot therapy devices that can be remotely monitored. Collected data are automatically entered into the system and sent to a data center (transparent to the user), where the information is monitored by a clinician through a secure website. To demonstrate the functionality of the system, an existing user-friendly home-compatible stroke therapy robotic device is utilized. A randomized, controlled, multisite clinical trial is designed to evaluate this combination of controlled rehabilitation therapy for stroke survivors with telehealth components. The model can be generalized in the future with the use of other home-based therapy and monitoring devices as needed for a specific patient. Fostering effective home treatments through the use of these devices will help determine the difference between functional independence and nursing home placement. The clinical trial will enroll 96 stroke patients and treat them at home for three months. These important considerations combine contemporary technology for service delivery and the potential for cost-savings. In a relatively short time, these advances will have a major beneficial impact on the delivery of stroke therapy to millions of rural stroke survivors. Kinetic Muscles, Inc. is an emerging company developing state-of-the-art therapy devices to fundamentally improve rehabilitation for people with neurologic injury such as stroke or traumatic brain injury (TBI). As an early stage medical device company, we regularly seek private funding to support growth objectives. Funding of this proposal would not only allow KMI to retain and add four full-time research and development personnel but would also facilitate additional funding from the private investment community to accelerate market deployment of innovative telerehabilitation therapy. This strategy has the realistic capability to provide a new level of accessible, affordable rehabilitative care for stroke patients. It is estimated that this current proposal will also create or retain four jobs between the Cleveland Clinic and Emory University. PUBLIC HEALTH RELEVANCE: The purpose of this research is to evaluate a therapy delivery system for stroke patients that provide accessible, affordable stroke care. User-friendly home therapy robots and a telerehabilitation system are combined to monitor and provide therapy that is accessible for patients in rural and underserved locations.